ono-2020
Small moleculeexperimental
Clinical trial activity
3 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started Jul 29, 2022 (NCT05507515)
Timeline
Indications
Mechanism of action
- UnclearUnclear
Unclear unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06881836 | Phase 2 | Apr 24, 2025 | Ono Pharmaceuticals |
| NCT06803823 | Phase 2 | Feb 1, 2025 | Ono Pharmaceuticals |
| NCT05507515 | Phase 1 | Jul 29, 2022 | Ono Pharmaceuticals |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Ono Pharmaceuticals | For profit | 3 | 3 | 2 | 2022 |
1 organizations
Page 1 / 1